Viewing Study NCT07006506

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 4:01 PM
Ignite Modification Date: 2026-02-10 @ 1:45 PM
Study NCT ID: NCT07006506
Status: RECRUITING
Last Update Posted: 2025-12-18
First Post: 2025-05-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Graft Versus Host Disease View
None Graft Vs Host Disease View
None Hematologic Malignancy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Graft Versus Host Disease View
None Graft Vs Host Disease View
None Hematologic Malignancy View
None Hematologic malignancy in morphologic remission View
None Belumosudil View
None Stem Cell Transplant View
None Memorial Sloan Kettering Cancer Center View
None 25-033 View